Study Stopped
COVID 19 Pandemic disabled team involved
MATERNAL AND NEONATAL SCREENING FOR GROUP B STREPTOCOCCI : A Follow up STUDY
Maternal And Neonatal Screening For Group B Streptococci in Fayoum Governrate: A Follow Up Study
1 other identifier
observational
N/A
1 country
1
Brief Summary
Group B Streptococcus (GBS), is a facultative gram positive diplococcus originally known for causing bovine mastitis and was not demonstrated to be a human pathogen until 1938. In the 1970s, GBS emerged as the leading cause of neonatal morbidity and mortality, with a frequency of 2-3 cases per 1,000 live births and case-fatality ratios as high as 50%
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jun 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2019
CompletedFirst Submitted
Initial submission to the registry
January 10, 2020
CompletedFirst Posted
Study publicly available on registry
January 14, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedMarch 31, 2022
March 1, 2022
1.6 years
January 10, 2020
March 17, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
prevalence of GBS in Fayoum
Percentage of maternal GBS infection and its reflection on neonatal infection
one year
Secondary Outcomes (1)
improve and simplify the diagnosis of GBS
one year
Study Arms (2)
group A
group A (+ve GBS) 300 pregnant of gestational age 35-37 weeks were screened by a group B streptococcal (GBS) conventional PCR assay. Patients who were followed till delivery without prolonged rupture of membrane were eligible to enter the study and details with regard to labor and delivery were recorded. Infant data were also recorded.
group B
group B (-ve GBS) 300 pregnant of gestational age 35-37 weeks were screened by a group B streptococcal (GBS) conventional PCR assay. Patients who were followed till delivery without prolonged rupture of membrane were eligible to enter the study and details with regard to labor and delivery were recorded. Infant data were also recorded.
Interventions
all participants were evaluated by vaginorectal specimens for the detection of GBS, The swabs are placed in Amies transport medium and sent to the microbiology laboratory for testing by conventional PCR assay.
Eligibility Criteria
pregnant females 35-37 weeks of gestational age attending the antenatal outpatient clinic at AlFayom University Hospital. All participants were screened by a group B streptococcal (GBS) conventional PCR assay. Patients who were followed till delivery without prolonged rupture of membrane were eligible to enter the study and details with regard to labor and delivery were recorded delivery was conducted at AlFayom university hospital. Infant data were also recorded.
You may qualify if:
- pregnant females 35-37 weeks of gestational age Patients who were followed till delivery without prolonged rupture of membrane
You may not qualify if:
- patients lost follow up and or had prolonged rupture of membrane\>12 hours
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
sahar M.Y elbaradie
Al Fayyum, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- associate Professor
Study Record Dates
First Submitted
January 10, 2020
First Posted
January 14, 2020
Study Start
June 1, 2019
Primary Completion
December 30, 2020
Study Completion
December 31, 2020
Last Updated
March 31, 2022
Record last verified: 2022-03